Latest Regulation News

SenSen Networks has reported its first full year of positive operating cash flow, driven by strong growth in its Smart Cities segment and strategic cost reductions.

Redivium Limited has initiated a comprehensive business review and advisor appointment process aimed at exploring restructuring options to enhance long-term shareholder value and governance.

G8 Education faces ASX scrutiny over its handling of sensitive information about a former employee, with the regulator questioning the company’s disclosure practices despite GEM’s insistence of compliance.

Alterity Therapeutics has responded to an ASX inquiry about its recent share price and volume spike, confirming no undisclosed information but highlighting imminent clinical data releases and investor roadshows as possible drivers.

Abacus Storage King has received a revised acquisition proposal from a consortium led by Ki Corporation and Public Storage, increasing their cash offer by 15% to A$1.65 per security. The independent board committee is opening a six-week due diligence window but urges securityholders to hold off on any action.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

OD6 Metals has resolved a regulatory investigation with a minor penalty, paving the way for renewed exploration at its Gulf Creek Copper Project. The company is set to advance drilling campaigns targeting high-grade copper, zinc, and silver mineralisation.

Critical Resources Limited has launched a detailed soil-geochemistry survey at its Amoco Gold-Antimony Project in NSW, aiming to sharpen drill targets ahead of planned maiden drilling. Assay results are expected by late August, marking a significant step in advancing exploration within a prolific regional corridor.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Native Mineral Resources has raised A$10 million through a share placement to fund the ramp-up of gold production at its Blackjack plant in Queensland, following its first gold pour ahead of schedule.

American Rare Earths reports high recoveries of key rare earth elements and significantly reduced impurities at its Halleck Creek project, marking a major step in its path to U.S. rare earth independence.